Vapocoolant (Pain Ease) Use for Venipuncture (NCT01712776) | Clinical Trial Compass
CompletedNot Applicable
Vapocoolant (Pain Ease) Use for Venipuncture
United States100 participantsStarted 2011-04
Plain-language summary
To determine the efficacy and safety of vapocoolant spray (Pain Ease Medium Stream) in decreasing the pain of venipuncture ("blood draw")
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient needing venipuncture ("blood draw') but not intravenous cannulation
* Adult 18 years and older up to and and including 80 years old
* Stable patient
* Mentally competent patient able to understand the consent form
Exclusion Criteria:
* Patients with any allergies to the spray components (e.g. 1,1,1,3,3 pentafluoropropane or 1,1,1,2, tetrafluoroethane )
* Critically ill or unstable (e.g. sepsis or shock)
* Extremes of age: geriatric (\> 80 years) or pediatric ( \< 18 years old)
* Pregnant
* Venipuncture site located in area of compromised blood supply. Examples include : patients with peripheral vascular disease, gangrene, Raynaud's disease, Buerger's disease.
* Venipuncture site located in area of insensitive skin; patients with a peripheral neuropathy including diabetic neuropathy.
* Patient intolerant of cold or with hypersensitivity to the cold.
* Patient unable or unwilling to give consent.
* Prior experience with vapocoolant spray
* Currently in another research trial
What they're measuring
1
Pain Scale on Numeric Rating Scale (NRS) ( 0 to 10)
Timeframe: Less than 10 minutes after stream application.